180 related articles for article (PubMed ID: 19854590)
1. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
4. Clearance of linezolid via continuous venovenous hemodiafiltration.
Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
[TBL] [Abstract][Full Text] [Related]
5. Penetration of linezolid into sternal bone of patients undergoing cardiopulmonary bypass surgery.
Metallidis S; Nikolaidis J; Lazaraki G; Koumentaki E; Gogou V; Topsis D; Nikolaidis P; Charokopos N; Theodoridis G
Int J Antimicrob Agents; 2007 Jun; 29(6):742-4. PubMed ID: 17374477
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
Slatter JG; Stalker DJ; Feenstra KL; Welshman IR; Bruss JB; Sams JP; Johnson MG; Sanders PE; Hauer MJ; Fagerness PE; Stryd RP; Peng GW; Shobe EM
Drug Metab Dispos; 2001 Aug; 29(8):1136-45. PubMed ID: 11454733
[TBL] [Abstract][Full Text] [Related]
7. Linezolid pharmacokinetics in pediatric patients: an overview.
Jungbluth GL; Welshman IR; Hopkins NK
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
[TBL] [Abstract][Full Text] [Related]
9. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
10. Age and sex effects on the pharmacokinetics of linezolid.
Sisson TL; Jungbluth GL; Hopkins NK
Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
[TBL] [Abstract][Full Text] [Related]
12. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
[TBL] [Abstract][Full Text] [Related]
14. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
[TBL] [Abstract][Full Text] [Related]
15. The effect of food on plasma and tissue concentrations of linezolid after multiple doses.
Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C
Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930
[TBL] [Abstract][Full Text] [Related]
16. Linezolid pharmacokinetics in an obese patient.
Mersfelder TL; Smith CL
Am J Health Syst Pharm; 2005 Mar; 62(5):464, 467. PubMed ID: 15745906
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
MacGowan AP
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139
[TBL] [Abstract][Full Text] [Related]
19. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
[TBL] [Abstract][Full Text] [Related]
20. Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: a case report.
Pea F; Cadeo B; Cojutti PG; Pecori D; Bassetti M
Ther Drug Monit; 2014 Oct; 36(5):687-9. PubMed ID: 24646731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
